M. Rafique et W. Adachi, EFFECTS OF INTRAPORTAL ADMINISTRATION OF CHEMOIMMUNOTHERAPEUTIC AGENTS ON NATURAL-KILLER-CELL ACTIVITY IN THE RAT-LIVER, Journal of surgical oncology, 60(3), 1995, pp. 154-159
To evaluate the effects of continuous intraportal chemotherapy on tumo
r immunity of the liver, natural killer (NK) cell activity was estimat
ed in the rat liver. In an in vitro study, NK-enriched mononuclear cel
ls collected from rat liver were incubated with 5-fluorouracil (5-FU)
alone and with a 5-fluorouracil/mitomycin C (5-FU/MMC) combination at
different concentrations. NK activity was measured after 24-hour incub
ation. In an in vivo study, the continuous intraportal administration
of chemotherapeutic (5-FU/MMC) and chemoimmunotherapeutic (5-FU/MMC/le
ntinan) agents was carried out in rats for 5 days, and NK-enriched mon
onuclear cells were then collected from the liver for the measurement
of NK activity. Neither 5-FU alone nor the 5-FU/MMC combination affect
ed NK activity in vitro. In the in vivo study, however, the 5-FU/MMC c
ombination significantly decreased NK activity, and the addition of le
ntinan recovered the activity to the control level. It can thus be con
cluded that the intraportal administration of chemotherapeutic agents
reduces NK activity in the liver and the addition of an immunostimulat
or to such agents prevents this reduction. (C) 1995 Wiley-Liss. Inc.